LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$378M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$252M |
| 3 |
iShares Gold Trust
IAU
|
+$227M |
| 4 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$226M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$168M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$140M |
| 2 |
iShares ESG Aware MSCI EM ETF
ESGE
|
+$140M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$116M |
| 4 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$109M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.66% |
| 2 | Healthcare | 3.17% |
| 3 | Financials | 3.02% |
| 4 | Consumer Discretionary | 2.48% |
| 5 | Industrials | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNT
4226
Fluent
FLNT
$106M
| $52K | ﹤0.01% |
7,330
| – | – |
|
4227
Femasys
FEMY
$8.39M
| $51K | ﹤0.01% |
+1,052
| New | +$35.6K |
|
4228
Rekor Systems
REKR
$82.6M
| $51K | ﹤0.01% |
28,699
-50,300
| -64% | -$144K |
|
4229
CorMedix
CRMD
$564M
| $50K | ﹤0.01% |
12,323
| – | – |
|
4230
Lipocine
LPCN
$17.1M
| $50K | ﹤0.01% |
3,691
-441
| -11% | -$6.87K |
|
4231
TScan Therapeutics
TCRX
$48.5M
| $50K | ﹤0.01% |
+16,000
| New | +$43.8K |
|
|
GTHX
4232
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $50K | ﹤0.01% |
10,090
| – | – |
|
|
SIEN
4233
DELISTED
Sientra, Inc.
SIEN
| $49K | ﹤0.01% |
5,869
-5,293
| -47% | -$72.1K |
|
|
RIBT
4234
DELISTED
RiceBran Technologies
RIBT
| $49K | ﹤0.01% |
7,281
| – | – |
|
4235
Bionano Genomics
BNGO
$12.5M
| $48K | ﹤0.01% |
59
+4
| +7% | +$4.12K |
|
4236
Smartbird Inc
BIRD
$19.5M
| $47K | ﹤0.01% |
+598
| New | +$60.4K |
|
|
TDAY
4237
USA Today Co
TDAY
$1.29B
| $47K | ﹤0.01% |
16,201
+3,260
| +25% | +$12.4K |
|
4238
Microvision
MVIS
$84.8M
| $47K | ﹤0.01% |
12,291
+1,500
| +14% | +$5.36K |
|
4239
PAVmed
PAVM
$36.5M
| $47K | ﹤0.01% |
111
+10
| +10% | +$4.83K |
|
4240
SGHC Ltd
SGHC
$7.57B
| $47K | ﹤0.01% |
+11,350
| New | +$87.4K |
|
4241
Zevra Therapeutics
ZVRA
$578M
| $47K | ﹤0.01% |
10,500
-50
| -0.5% | -$228 |
|
4242
KULR Technology Group
KULR
$112M
| $46K | ﹤0.01% |
+3,699
| New | +$49.4K |
|
4243
ThredUp
TDUP
$765M
| $45K | ﹤0.01% |
17,811
+522
| +3% | +$2.82K |
|
4244
Precigen
PGEN
$1.94B
| $44K | ﹤0.01% |
32,571
-473
| -1% | -$702 |
|
4245
Vivani Medical
VANI
$109M
| $44K | ﹤0.01% |
7,253
+20
| +0.3% | +$108 |
|
4246
Innoviz Technologies
INVZ
$84.1M
| $43K | ﹤0.01% |
+10,995
| New | +$42.9K |
|
4247
Arcadia Biosciences
RKDA
$1.42M
| $43K | ﹤0.01% |
1,076
-25
| -2% | -$1.15K |
|
|
ZEPP
4248
Zepp Health
ZEPP
$63.8M
| $43K | ﹤0.01% |
5,788
| – | – |
|
|
FCRD
4249
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $43K | ﹤0.01% |
+12,256
| New | +$48K |
|
4250
Heron Therapeutics
HRTX
$93.4M
| $42K | ﹤0.01% |
15,050
-1,450
| -9% | -$5.82K |
|
Similar funds
LPL Financial's Q2 2022 Portfolio in Review
As of Q2 2022, LPL Financial held 4,602 positions worth $105B, down 9.5% from $116B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
LPL Financial deployed $5.93B of net new capital in Q2 2022, opening 421 new positions and adding to 2,316 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 14,943,726 shares worth $348M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $140M trimmed.
- LPL Financial's largest Q2 2022 buy was Dimensional US Core Equity 2 ETF: 14,943,726 shares worth $348M.
- LPL Financial added most to State Street Health Care Select Sector SPDR ETF in Q2 2022, an estimated $252M increase.
- LPL Financial's biggest Q2 2022 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $140M.
- LPL Financial fully exited MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q2 2022, selling an estimated $4.43M.
- LPL Financial's ten largest holdings make up 18% of its $105B portfolio in Q2 2022.
- LPL Financial opened 421 new positions and closed 184 in Q2 2022.
- LPL Financial's portfolio value fell 9.5% quarter-over-quarter to $105B.
Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.